November 8 from 1:30 pm – 2:15 pm EST
Innovation Theater B | Supported By: Lilly USA, LLC
Program Description
Join us as Dr. Elizabeth Perkins presents the newest data on Taltz® (ixekizumab) injection & Zepbound® (tirzepatide) injection including an affordability solution.
Visit the Lilly booth to learn about this industry session and discover why data matters today and tomorrow.
This program is developed and offered by Lilly USA, LLC. This is not an official program of the American College of Rheumatology.
Please see Prescribing Information and Medication Guide for Taltz. See Instructions for Use.
Please see Prescribing Information, including Boxed Warning about possible thyroid tumors, including thyroid cancer, and Medication Guide for Zepbound. Please see Instructions for Use.
Taltz® and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Zepbound® and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
CMAT-60430 10/2026 ©Lilly USA, LLC 2026. All rights reserved.
Speaker
Presenter: Elizabeth Perkins, MD
Rheumatology Care Center
Founding Physician
Birmingham, Alabama